SARM1 and amyotrophic lateral sclerosis: In the present study we found that genetic suppression of Wallerian-like axon destruction by deletion of Sarm1 neither attenuates axon degeneration nor alters hallmark features of disease progression in the SOD1G93A transgenic mouse model of ALS.